Intuitive Surgical (ISRG) ROE - Return on Equity
Current and historical Return on Equity (ROE) values for Intuitive Surgical (ISRG) over the last 10 years.
|Medical||Medical Instruments Manufacturing||$41.513B||$2.704B|
|Intuitive Surgical, Inc. is the global technology leader in minimally invasive robotic-assisted surgery. The Company's `da Vinci Surgical System` enables surgeons to operate minimally invasively through a few small incisions or the belly button from a nearby ergonomic console. The da Vinci System features a magnified 3D HD vision system and tiny wristed instruments that bend and rotate far greater than the human hand. As a result of this technology, da Vinci enables surgeons to operate with enhanced vision, precision and control. The original prototype for the da Vinci System was developed in the late 1980s at the former Stanford Research Institute under contract to the U.S. Army. While initial work was funded in the interest of developing a system for remotely performing battlefield surgery, possible commercial applications were even more compelling.|